Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.
The risk of invasive listeriosis after exposure to L. monocytogenes is very low; although exposure is common, disease is rare. It was the consensus of an expert panel that no testing or treatment is indicated for an asymptomatic person with elevated risk of invasive listeriosis who ate a product recalled because of L. monocytogenes contamination. Patient management decisions for asymptomatic or mildly symptomatic persons are appropriately made on a case-by-case basis, informed by clinical judgment and the likelihood of exposure of the patient.
As a result of the 2011 outbreak of listeriosis linked to cantaloupe, CDC created the guidance document, "Suggested framework for medical management of persons at elevated risk for invasive listeriosis who are exposed to Listeria monocytogenes" that can be found at http://bit.ly/1lsti2n. Although the guidance document suggests stool culture as an option, it is important to note that stool testing for Listeria has not been evaluated as a screening tool for listeriosis and, in general, is not recommended for the diagnosis of listeriosis. Ingestion of Listeria occurs frequently because the bacterium is commonly present in the environment. Therefore, intermittent fecal carriage and shedding of Listeria is frequent (about 5% in unselected populations, but substantial variation exists) and rarely indicative of infection. Stool culture for Listeria may also have low sensitivity and, is not available in the vast majority of clinical laboratories.
For a list of all recalled products, please visit: http://www.in.gov/isdh/20643.htm.
Page last updated: August 1, 2016
Page last reviewed: August 1, 2016